Skip to content
10-K

Annual Report

Impact BioMedical, INC. IBO

0001641172-25-001199

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 26, 2025 12.09M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$2.85M
Cash And Equivalents FY 2024 · Dec 31, 2023 $1K
Stockholders Equity FY 2024 · Dec 31, 2023 $25.22M
Current Liabilities FY 2024 · Dec 31, 2023 $13.14M
Total Liabilities FY 2024 · Dec 31, 2023 $16.37M
Current Assets FY 2024 · Dec 31, 2023 $332K
Total Assets FY 2024 · Dec 31, 2023 $44.63M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.07
Eps Basic FY 2024 · Dec 31, 2023 −$0.07
Sga Expense FY 2024 · Dec 31, 2023 $315K
Rd Expense restated FY 2024 · Dec 31, 2023 $1.69M
Net Income restated FY 2024 · Dec 31, 2023 −$4.34M
Operating Income FY 2024 · Dec 31, 2023 −$4.03M
Short Term Debt FY 2024 · Sep 30, 2023 $11.9M